TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 47 filers reported holding TYRA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,949,818 | -18.3% | 141,599 | +1.0% | 0.00% | – |
| Q2 2023 | $2,387,061 | +38.1% | 140,168 | +30.3% | 0.00% | – |
| Q1 2023 | $1,728,200 | +115.0% | 107,542 | +1.7% | 0.00% | – |
| Q4 2022 | $803,829 | -11.9% | 105,767 | +1.9% | 0.00% | – |
| Q3 2022 | $912,000 | +23.6% | 103,808 | +0.7% | 0.00% | – |
| Q2 2022 | $738,000 | -31.1% | 103,134 | +3.0% | 0.00% | – |
| Q1 2022 | $1,071,000 | -26.4% | 100,104 | -3.3% | 0.00% | – |
| Q4 2021 | $1,456,000 | – | 103,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |